Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FoxMeyer's acquisition of Zahn

Executive Summary

Federal Trade Commission has requested more data from both FoxMeyer and the Louis Zahn drug company on the merger. FoxMeyer expects the information to be provided in time for FTC to make a decision in December. FoxMeyer announced the acquisition of the Chicago drug distribution business Aug. 25 ("The Pink Sheet" Aug. 29, T&G-1). FTC is taking a closer look at mergers in the wholesaling industry, as illustrated by the commission's recent announcement that it would block McKesson's acquisition of Alco Health Services and Northwestern Drug.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS014556

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel